Authors
Loading...
Mechanistic review demonstrates distinct temporal and anatomical roles of CTLA-4 and PD-1 checkpoints in cancer, highlighting distinct clinical therapeutic profiles for immune checkpoint inhibitors.
Buchbinder et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: